We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Improved Detection of Lung Cancer Nodules with CAD Chest X-Ray Technology

By HospiMedica International staff writers
Posted on 07 Mar 2011
A new study revealed that radiologists using a computer-aided detection (CAD) system were able to detect smaller lung nodules, including those that were primary lung cancer. More...


Riverain Medical (Dayton, OH, USA), a developer of CAD and advanced visualization technologies, announced the study's findings that have been published on the European Society of Radiology's website (please see related links below). Investigators compared two versions of Riverain Medical's CAD technology, OnGuard 5.1 and OnGuard 1.0.

"By using OnGuard 5.1 in tandem with a standard chest X-ray, our radiologists are now able to detect smaller lung nodules that would have previously gone unnoticed," said Dr. Matthew Freedman, lead investigator of the study and associate professor of oncology at the Lombardi Comprehensive Cancer Center at Georgetown University (Washington DC, USA). "It's clear from our research that OnGuard CAD technology has improved significantly over the past 10 years. Improved sensitivity and a lower false positive rate allow radiologists to detect early-stage lung cancer sooner, giving them more confidence in diagnosing the patient."

Fifteen radiologists participated in the reader study, which analyzed more than 250 chest X-rays (approximately a 2:1 cancer negative to positive ratio). Compared to its earlier version, investigators found OnGuard 5.1 provided nearly 50% higher machine sensitivity for cancer detection, while significantly reducing the number of false positives per image.

"Initial results of the National Lung Screening Trial demonstrate for the first time that the early detection of lung cancer can save lives," said Steve Worrell, chief technology officer of Riverain Medical. "We're excited to play a key role in the early detection of lung cancer. OnGuard's CAD markings give radiologists a second set of eyes, allowing radiologists to find cancerous nodules at their earliest and most treatable stage."

The European Society of Radiology's annual meeting, ECR [European Congress of Radiology] 2011, will take in Vienna, Austria from March 3-7, 2011.

Related Links:
Riverain Medical
European Society of Radiology
Georgetown University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.